Against a backdrop of achievements yielded from public/private collaborations in the context of the pandemic response, we focused our latest virtual briefing on the crucial role such partnerships play in furthering biopharma and medical devices innovation. We share highlights from the event and provide the catch-up recording in this brief summary.
PMC was delighted to feature in the latest LBIC newsletter from the London BioScience Innovation Centre discussing how the ILAP scheme is helping to secure the UK’s position as a life science superpower. Learn more.
In March 2021, the government published its document Saving and Improving lives: The Future of Clinical Research Delivery. The paper laid out an ambitious vision for a more patient-centred, pro-innovation and data-enabled clinical research environment in the UK. Following the publication of the implementation plan in June, we summarise the key themes in this article.
Join PMC for our next virtual breakfast briefing on Wednesday 21st July 2021 at 8am. Our topic for this session is “The role of public/ private collaborations to further biopharma and medical devices innovation”. We are delighted to welcome Nicki Bromwich, Chief Operating Officer of MedCity who will join Dr Malcolm Barratt-Johnson, Managing Director of PMC to discuss the ecosystem of public/ private collaboration and how it supports innovation. Read more and register.
Patient and public involvement in research is increasingly regarded as best practice. In this Q&A article, we interviewed Clinical Development Consultant Dr Joanne James to discuss her perspectives and experiences of these important initiatives, and their impact on research quality.
The MHRA's recently launched Innovative Licensing and Access Pathway scheme (ILAP) forms part of a bold vision for the UK to incentivise and support life sciences development as we emerge into a post-Brexit regulatory and clinical trials environment. PharmaMedic Consultancy is currently supporting several clients with their applications, and in this article, we share more insights about the scheme and how it stands to benefit patients and sponsors.
We were exceptionally proud to sponsor a session at the ABPI conference last week at such a critical juncture for the UK pharmaceutical industry. The speakers, including Matt Hancock, Dr June Raine and Professor Sir John Bell, provided inspiration and food for thought- we certainly feel optimistic about the future of the UK as a life sciences powerhouse. To read our event summary, click here.
We enjoyed another successful PharmaMedic virtual breakfast briefing on 22nd April focusing on practical insights for consultants. If you missed it, you can catch up on the key takeaways including key questions on latest implications of the changes in IR35 legislation for consultants here. We are also delighted to share the video replay of the event.
PharmaMedic Consultancy is proud to feature as a session sponsor at the virtual ABPI Annual Conference on Thursday, 29 April 2021. The theme of this year's event is "Building a Life Sciences Superpower" – a vision and ambition which we at PharmaMedic wholeheartedly support. Read more about our participation and the event.
More than ever over the last 12 months, our use of patient data has been essential to support public health and gain information about vital medicines. In this article, we interview Dr Sheuli Porkess, Director of Actaros Consultancy for her insights on the latest trends, regulatory adoption and her expectations and hopes for the future.
